Details about Rebecca M. Henderson
Access statistics for papers by Rebecca M. Henderson.
Last updated 2010-04-11. Update your information in the RePEc Author Service.
Short-id: phe120
Jump to Journal Articles Chapters
Working Papers
2013
- Managers and Market Capitalism
Harvard Business School Working Papers, Harvard Business School
2006
- Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
NBER Working Papers, National Bureau of Economic Research, Inc View citations (37)
2005
- Inertia and Incentives: Bridging Organizational Economics and Organizational Theory
NBER Working Papers, National Bureau of Economic Research, Inc View citations (61)
- Platform Owner Entry and Innovation in Complementary Markets: Evidence from Intel
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1)
See also Journal Article in Journal of Economics & Management Strategy (2007)
1999
- Balancing Incentives: The Tension Between Basic and Applied Research
NBER Working Papers, National Bureau of Economic Research, Inc View citations (47)
- The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research
NBER Working Papers, National Bureau of Economic Research, Inc View citations (23)
1997
- Public-Private Interaction and the Productivity of Pharmaceutical Research
NBER Working Papers, National Bureau of Economic Research, Inc View citations (29)
1995
- Universities as a Source of Commercial Technology: A Detailed Analysis of University Patenting 1965-1988
NBER Working Papers, National Bureau of Economic Research, Inc View citations (65)
Also in Working Papers, Tel Aviv (1995) View citations (12)
See also Journal Article in The Review of Economics and Statistics (1998)
1994
- Measuring competence?: exploring firm effects in pharmaceutical research
Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management View citations (471)
- Of life cycles real and imaginary: the unexpectedly long old age of optical lithography
Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management 
See also Journal Article in Research Policy (1995)
- The evolution of integrative capability: innovation in cardiovascular drug discovery
Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management View citations (58)
1993
- Racing or spilling?: the determinants of research productivity in ethical drug discovery
Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management View citations (2)
- Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry
NBER Working Papers, National Bureau of Economic Research, Inc View citations (13)
- Scale, scope and spillovers: the determinants of research productivity in ethical drug discovery
Working papers, Massachusetts Institute of Technology (MIT), Sloan School of Management View citations (7)
1992
- Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations
NBER Working Papers, National Bureau of Economic Research, Inc View citations (1101)
- Ivory Tower Versus Corporate Lab: An Empirical Study of Basic Research and Appropriability
NBER Working Papers, National Bureau of Economic Research, Inc View citations (42)
Undated
- Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery
Working Papers, Department of Economics, University of Lancaster View citations (51)
See also Journal Article in RAND Journal of Economics (1996)
Journal Articles
2007
- Platform Owner Entry and Innovation in Complementary Markets: Evidence from Intel
Journal of Economics & Management Strategy, 2007, 16, (1), 1-34 View citations (144)
See also Working Paper (2005)
2005
- Patent Citations and the Geography of Knowledge Spillovers: A Reassessment: Comment
American Economic Review, 2005, 95, (1), 461-464 View citations (82)
2003
- Discontinuities and senior management: assessing the role of recognition in pharmaceutical firm response to biotechnology
Industrial and Corporate Change, 2003, 12, (2), 203-233 View citations (62)
2001
- Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
Journal of Health Economics, 2001, 20, (6), 1033-1057 View citations (68)
1998
- Universities As A Source Of Commercial Technology: A Detailed Analysis Of University Patenting, 1965-1988
The Review of Economics and Statistics, 1998, 80, (1), 119-127 View citations (420)
See also Working Paper (1995)
1996
- Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery
RAND Journal of Economics, 1996, 27, (1), 32-59 View citations (424)
See also Working Paper
1995
- Of life cycles real and imaginary: The unexpectedly long old age of optical lithography
Research Policy, 1995, 24, (4), 631-643 View citations (46)
See also Working Paper (1994)
1994
- Racing To Invest? The Dynamics of Competition in Ethical Drug Discovery
Journal of Economics & Management Strategy, 1994, 3, (3), 481-519 View citations (76)
1993
- Underinvestment and Incompetence as Responses to Radical Innovation: Evidence from the Photolithographic Alignment Equipment Industry
RAND Journal of Economics, 1993, 24, (2), 248-270 View citations (269)
Chapters
2001
- Publicly Funded Science and the Productivity of the Pharmaceutical Industry
A chapter in Innovation Policy and the Economy, Volume 1, 2001, pp 1-34 View citations (17)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|